SAL 726 (Mycophenolate Mofetil 250 mg)
Pill with imprint SAL 726 is White, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Strides Arcolab Limited.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SAL 726
Mycophenolate Mofetil
- Imprint
- SAL 726
- Strength
- 250 mg
- Color
- White
- Size
- 1.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Strides Arcolab Limited
- National Drug Code (NDC)
- 59762-0703
- Inactive Ingredients
-
croscarmellose sodium,
FD&C Red No. 3,
ferric oxide yellow,
gelatin,
magnesium stearate,
sodium lauryl sulfate,
titanium dioxide,
povidone k30,
microcrystalline cellulose
Note: Inactive ingredients may vary.
More about mycophenolate mofetil
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 50 Reviews
- Drug class: selective immunosuppressants
- FDA Alerts (3)
Consumer resources
- Patient Information
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Other brands
- CellCept
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.